Current Diabetes Reviews


Norman E. Cameron
University of Aberdeen

Personal Subscription
Become EABM
Become Reviewer

Cardiovascular Disease Risk of Type 2 Diabetes Mellitus and Metabolic Syndrome: Focus on Aggressive Management of Dyslipidemia

Volume:1   Issue: 2
Pp: 127-135
James M. Falko, Robert J. Moser, Sophia B. Meis and Teresa Caulin-Glaser
DOI: 10.2174/1573399054022848

The Metabolic Syndrome and Cardiovascular Risk

Volume:1   Issue: 2
Pp: 137-143
Gang Hu, Qing Qiao and Jaakko Tuomilehto
DOI: 10.2174/1573399054022820

Management of the Metabolic Syndrome as a Strategy for Preventing the Macrovascular Complications of Type 2 Diabetes: Controversial Issues

Volume:1   Issue: 2
Pp: 145-158
Carlos A. Aguilar-Salinas, Roopa Mehta, Rosalba Rojas, Francisco J. Gomez-Perez, Gustavo Olaiz and Juan A. Rull
DOI: 10.2174/1573399054022767

Platelet in Progression of Atherosclerosis: A Potential Target in Diabetic Patients

Volume:1   Issue: 2
Pp: 159-165
Hidenori Koyama and Yoshiki Nishizawa
DOI: 10.2174/1573399054022758

Molecular Mechanisms of Skeletal Muscle Insulin Resistance in Type 2 Diabetes

Volume:1   Issue: 2
Pp: 167-174
Karim Bouzakri, Heikki A. Koistinen and Juleen R. Zierath
DOI: 10.2174/1573399054022785

Down-Regulation of Angiogenic Inhibitors: A Potential Pathogenic Mechanism for Diabetic Complications

Volume:1   Issue: 2
Pp: 183-196
Jian-xing Ma, Sarah X. Zhang and Joshua J. Wang
DOI: 10.2174/1573399054022839

Angiotensin II-Induced Signaling Pathways in Diabetes

Volume:1   Issue: 2
Pp: 197-202
Mario B. Marrero, David Fulton, David Stepp and David M. Stern
DOI: 10.2174/1573399054022802

Gestational Diabetes Mellitus: A Review from 2004

Volume:1   Issue: 2
Pp: 203-213
Richard X. Davey
DOI: 10.2174/1573399054022776

Basal Bolus Dosing: A Clinical Experience

Volume:1   Issue: 2
Pp: 215-220
Allen B. King and Dana U. Armstrong
DOI: 10.2174/1573399054022794